← Browse by Condition
Medical Condition

lymphoma t cell peripheral

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06947967 Phase 3
Recruiting

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Enrollment
224 pts
Location
China
Sponsor
Chipscreen Biosciences, Ltd.
View Trial →